A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
Piscataway-based GenScript USA Inc. said Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection ...
An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody appears ...
Scientists have identified a new pair of antibodies that could fend off multiple COVID-19 variants. Found in people who successfully recovered from the illness, these antibodies attach to a part of ...
(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...
Morning Overview on MSN
It’s not just DNA: scientists uncover the real reason some people get much sicker
A growing body of research has identified a hidden immune defect, not written in DNA, that helps explain why certain people ...
In this ongoing, randomized, phase 3 trial, sotrovimab (a SARS-CoV-2–targeted monoclonal antibody) or placebo was administered to outpatients within 5 days after the onset of Covid-19 symptoms. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results